EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size



Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size



Journal of Clinical Endocrinology and Metabolism 66(6): 1144-1151



This study was designed to determine whether exogenous hCG alone can complete spermiogenesis in men with isolated hypogonadotropic hypogonadism (IHH). hCG was administered to 22 men with IHH until maximal testicular growth was achieved. Their mean testicular volume increased from 5.5 +/- 1.1 (+/- SE) mL (pretreatment) to 10.8 +/- 1.6 mL (maximum) during treatment (P less than 10(-6)). The maximum mean testicular volume was highly positively correlated with initial volume (r = 0.84; P less than 10(-6)). All men attained normal serum testosterone levels, and 7 of 22 men achieved supraphysiological serum estradiol levels. During hCG treatment, 14 of the 22 men had sperm appear in their semen. Six of 11 men with complete gonadotropin deficiency, defined as an initial mean testicular volume less than 4 mL, became sperm positive during hCG treatment. In contrast, 9 of 11 men with partial gonadotropin deficiency (initial mean testicular volume of 4 mL or more) produced sperm during treatment (P less than 0.001). Sperm concentration was highly positively correlated with both pretreatment (r = 0.65; P less than 0.01) and final testicular volume (r = 0.73; P less than 0.0001). Of 13 men attempting to impregnate their partners, 7 were successful in initiating conception; a total of 8 pregnancies ensued. The sperm concentration at the time of conception was less than 10 million/mL in all but 1 man. Our study demonstrates that hCG, in the absence of exogenous FSH, can complete spermiogenesis in men with partial gonadotropin deficiency. The response to hCG in men with IHH is predicted by the initial testicular volume.

(PDF emailed within 0-6 h: $19.90)

Accession: 005533251

Download citation: RISBibTeXText

PMID: 3372679

DOI: 10.1210/jcem-66-6-1144



Related references

The testicular response to human chorionic gonadotropin and human chorionic gonadotropin human menopausal gonadotropin treatment in patients with hypogonadotropic eunuchoidism influence of endogenous fsh. Journal of Steroid Biochemistry 20(6 PART B): 1603, 1984

Testicular responsiveness to long term administration of human chorionic gonadotropin and human menopausal gonadotropin in patients with hypogonadotropic hypogonadism. Hormone Research (Basel) 23(1): 21-30, 1986

Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. Journal of Clinical Endocrinology and Metabolism 61(4): 746-752, 1985

Testicular responsiveness to chronic human chorionic gonadotropin administration in hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 55(1): 76-80, 1982

The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. European Journal of Endocrinology 149(1): 23-29, 2003

Effects of preceding androgen therapy on testicular response to human pituitary gonadotropin in hypogonadotropic hypogonadism: a study of three patients. Fertility and Sterility 35(1): 64-68, 1981

Testicular responsiveness to chronic administration of human chorionic gonadotropin 1500 iu every 6 days in untreated hypogonadotropic hypogonadism. Journal Of Andrologyuppl: 92-P, 1985

Induction of spermatogenesis in isolated hypogonadotropic hypogonadism with exogenous human chorionic gonadotropin. Journal of Endocrinological Investigation 4(2): 217-219, 1981

Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology 139(3): 298-303, 1998

Testicular responsiveness to human chorionic gonadotropin during transient hypogonadotropic hypogonadism induced by androgenic anabolic steroids in power athletes. Journal of Steroid Biochemistry 25(1): 109-112, 1986

The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization. Clinical Endocrinology 88(1): 77-87, 2017

Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. Journal of Clinical Endocrinology and Metabolism 94(3): 780-785, 2008

Urinary testosterone response to human chorionic gonadotropin. Evaluation of male patients with hypogonadotropic hypogonadism. Fertility and Sterility 20(4): 632-638, 1969

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study. Asian Journal of Andrology 2019, 2019

Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertility & Sterility. 70(2): 256-262,., 1998